Is AKBA stock safe? | Glauxie AI

Q: Is AKBA stock safe?

Akebia Therapeutics, Inc. (AKBA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO John Butler. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational... Employees: 40,000.

Q: What are the risks of investing in AKBA?

Identify key risks of investing in AKBA — debt, competition, volatility, and sector headwinds.

Q: Is AKBA a good long-term investment?

Evaluate AKBA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does AKBA have?

Review AKBA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is AKBA stock safe?

🦉

Akebia Therapeutics, Inc. (AKBA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJohn Butler

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the...

Key Executives

Name	Title
Carolyn Rucci	Senior Vice President, Chief Legal Officer & Secretary
Erik John Ostrowski	Chief Business Officer, Senior Vice President, Chief Financial Officer & Treasurer
John Butler	Chief Executive Officer, President & Director
Justin McCue	Senior VP & Chief Technology Officer
Kimberly Garko	Senior Vice President & Chief Technical Officer
Mercedes Carrasco	Senior Director of Investor & Corporate Communications

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

AKBA Profile Financials

What are the risks of investing in AKBA? Is AKBA a good long-term investment? How much debt does AKBA have?